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Abstract
Background: Our first predictor of protein disorder was published just over a decade ago in the
Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z,
Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino
acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90–95).
By now more than twenty other laboratory groups have joined the efforts to improve the
prediction of protein disorder. While the various prediction methodologies used for protein
intrinsic disorder resemble those methodologies used for secondary structure prediction, the two
types of structures are entirely different. For example, the two structural classes have very different
dynamic properties, with the irregular secondary structure class being much less mobile than the
disorder class. The prediction of secondary structure has been useful. On the other hand, the
prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more
than 100 year-old views relating protein structure and function. Experimentalists have been
providing evidence over many decades that some proteins lack fixed structure or are disordered
(or unfolded) under physiological conditions. In addition, experimentalists are also showing that,
for many proteins, their functions depend on the unstructured rather than structured state; such
results are in marked contrast to the greater than hundred year old views such as the lock and key
hypothesis. Despite extensive data on many important examples, including disease-associated
proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our
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knowledge, current biochemistry books don't present even one acknowledged example of a
disorder-dependent function, even though some reports of disorder-dependent functions are
more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the
results from other bioinformatics studies of intrinsic disorder are demanding attention for these
proteins.
Results:  Disorder prediction has been important for showing that the relatively few
experimentally characterized examples are members of a very large collection of related
disordered proteins that are wide-spread over all three domains of life. Many significant biological
functions are now known to depend directly on, or are importantly associated with, the unfolded
or partially folded state. Here our goal is to review the key discoveries and to weave these
discoveries together to support novel approaches for understanding sequence-function
relationships.
Conclusion: Intrinsically disordered protein is common across the three domains of life, but
especially common among the eukaryotic proteomes. Signaling sequences and sites of
posttranslational modifications are frequently, or very likely most often, located within regions of
intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different
structures with different partners. Also, the flexibility of intrinsic disorder helps different
disordered regions to bind to a common binding site on a common partner. Such capacity for
binding diversity plays important roles in both protein-protein interaction networks and likely also
in gene regulation networks. Such disorder-based signaling is further modulated in multicellular
eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much
more often than to regions of structure. Associating alternative splicing with disorder rather than
structure alleviates theoretical and experimentally observed problems associated with the folding
of different length, isomeric amino acid sequences. The combination of disorder and alternative
splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways,
thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell
differentiation and multicellularity. Finally, several recent small molecules of interest as potential
drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder
of one of the partners. Study of these examples has led to a new approach for drug discovery, and
bioinformatics analysis of the human proteome suggests that various disease-associated proteins
are very rich in such disorder-based drug discovery targets.
Background
More than seventy years ago, it was speculated that anti-
body binding depends on unfolded rather than structured
protein [1,2]. Specifically, Linus Pauling suggested that
high flexibility enables one antibody molecule to bind to
differently shaped antigens. The specific idea was that of
conformational selection in which the flexible antibody
would randomly fluctuate among the different structures,
with binding by a particular antigen selecting the structure
that fits from the other conformers among the ensemble
[2]. The current body of evidence suggests that there are
approximately two broad classes of antibodies, specific
and non-specific. The sequence of a highly specific, high-
affinity antibody folds into a specific structure that fits
with its cognate antigen (with perhaps slight structural
shifts of both the antibody and antigen). On the other
hand, at least some of the low affinity, nonspecific anti-
bodies contains binding sites that are disordered in isola-
tion but become differently folded when bound to
different partners. A recent assembly of structural data on
antibody-antigen interactions supports the early conjec-
tures cited above (manuscript in preparation).
More recently, involvement of intrinsic disorder in molec-
ular recognition has been suggested to involve at least two
possible mechanisms [3]. Conformational selection, as
described by Pauling [2] and later by Karush [4], is the first
mechanism. Alternatively, a local part of the binding
region could form an interaction followed by concomi-
tant binding and folding over the remainder of the inter-
face [5-7]. While described sometime ago [6], this second
mechanism was recently described in terms of folding
funnel concepts and called the "fly casting mechanism"
[7]. For two recently studied molecular recognition
events, experimental evidence has been provided for the
latter mechanism [8,9]. Both of these recently studied
interfaces are fairly large and extend over significant
lengths of the intrinsically disordered proteins. Mixed
mechanisms of course are possible, with a subregion of
the interface interacting via conformational selection, fol-BMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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might be due in significant degree to the overall size of the
interaction surface.
The existence of unstructured, or incompletely structured,
proteins under physiological conditions began to be
reported almost sixty years ago, with several additional
reports in the following decades [4,10-13]. Since the
1970s, an increasingly strong stream of disordered protein
examples has been revealed, and many of these are
described in our database of intrinsically disordered pro-
teins [14,15]. This database also contains a bibliography
that is showing explosive growth, especially over the last
few years.
The crowded conditions inside the cell have been sug-
gested to cause intrinsically disordered proteins to fold
into 3D structure. To test this possibility, intrinsically dis-
ordered proteins were subjected to molecular crowding by
adding high concentrations of agents such as glucose.
Such in vitro 
In-cell NMR experiments indicate that some proteins or
protein regions remain unfolded even when crowding
occurs inside a cell [18-20]. Another in-cell NMR report
[21] involving some of the same authors was later
retracted because protein leakage from the cells led to mis-
leading data [22]. The earlier experiments [18,19] may not
have suffered from the same leakage problems, which
might have been specific for the protein used in the later
studies [22]. Overall, these experiments provide addi-
tional evidence that intrinsically disordered proteins
remain incompletely folded inside the cell, but additional
experiments need to be carried out in order to increase
confidence in these results.
A number of different terms have been used to describe
these proteins, including rheomorphic [23], natively
denatured [24], natively unfolded [25], intrinsically
unstructured [26], and several variants of disordered [27-
29]. By now, several reviews on these proteins have
appeared [16,17,30-34]. We use "intrinsically disordered"
to describe all types of incompletely folded proteins and
regions, and we use "natively unfolded" or "intrinsically
unstructured" to indicate random-coil-like and pre-mol-
ten globular forms. Collapsed random coils as recently
described for polyQ [35,36] are similar to, if not identical
with, the premolten globule form and in our view these
structures fit into the "natively unfolded" category. How-
ever, there is not a consensus in this field regarding
nomenclature, which suggests the need for a disordered
protein ontology.
Just as the amino acid sequence codes for protein struc-
ture, so might the sequence also code for lack of structure
or disorder. Development of a predictor of protein disor-
der is one way to test the hypothesis that disorder is
encoded by the amino acid sequence. Furthermore, study
of disorder prediction provides a means to understand
"the protein disorder code." For example, Figure 1A shows
that "natively unfolded" proteins (a subset of intrinsically
disordered proteins that have little or no ordered structure
under physiologic conditions and behave as random coils
or pre-molten globules [37-39]) are specifically localized
within a unique region of charge-hydropathy phase space,
indicating that a combination of low overall hydropathy
and high net charge represent a unique structural feature
of "natively unfolded" proteins [37]. In more general
terms, certain amino acid residues have been found to be
highly "order-promoting" (namely cysteine, tryptophan,
tyrosine, isoleucine, phenylalanine, valine, leucine, histi-
dine, threonine, and asparagine) while others are highly
"disorder-promoting" (namely aspartic acid, methionine,
lysine, arginine, serine, glutamine, proline, and glutamic
acid) [40-42]. These order-inducing and disorder-induc-
ing amino acid trends are further illustrated by Figure 1B,
which depicts the relative amino acid compositions of
intrinsically disordered regions available in the DisProt
database [15,43] in comparison with a set of structured
(or ordered) proteins [40]. In this case, these amino acid
compositions were compared by means of a profiling
approach [30,44].
During the fourth Critical Assessment of Structure Predic-
tion (CASP) experiment, we worked with the meeting
organizers to carry out disorder prediction on the various
protein targets. This trial was deemed a success (C.J.
Brown, unpublished), so disorder prediction was
included in the subsequent CASP 5, 6, and 7 experiments
[45-47]. Inclusion of disorder prediction in the CASP
experiments has stimulated a rapid increase in the
number of such predictors, with at least 25 different pre-
dictors having been developed by now. A collection of
links to many of these is maintained at the Database of
Disordered Protein website http://www.disprot.org.
Several disordered protein predictors have been compared
in recent publications [40,45-51]. As more disordered
proteins have been identified, and as more sophisticated
machine learning methods have been applied, the per res-
idue prediction accuracy has risen from ~70% to ~85%. ABMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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Peculiarities of the amino acid sequences of intrinsically disordered proteins Figure 1
Peculiarities of the amino acid sequences of intrinsically disordered proteins. A. Mean net charge versus mean 
hydropathy plot (charge-hydropathy plot) for the set of 275 folded (blue squares) and 91 natively unfolded proteins (red cir-
cles) [37]. B. Amino-acid composition, relative to the set of globular proteins Globular-3D, of intrinsically disordered regions 
10 residues or longer from the DisProt database. Dark gray indicates DisProt 1.0 (152 proteins), whereas light gray indicates 
DisProt 3.4 (460 proteins). Amino acid compositions were calculated per disordered regions and then averaged. The arrange-
ment of the amino acids is by peak height for the DisProt 3.4 release. Confidence intervals were estimated using per-protein 
bootstrapping with 10,000 iterations [40].
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likely-to-be significant impediment to further improve-
ment is the misclassification of the residues in the training
sets.
Application of the disorder predictors to various organ-
isms in the three domains of life, namely, prokaryotes,
archaea, and eukaryotes, reveals a large increase in disor-
der among the eukaryotes compared to the other two
types of organisms [48,52,53]. One related speculation is
that more disorder is needed for signaling and coordina-
tion among the various organelles in the more complex
eukaryotic domain [54].
The recent explosion of papers on intrinsically disordered
protein contains many new discoveries on these proteins
by a large number of investigators. There is neither time
nor space to adequately cover these important advances.
Herein we focus mainly on our own work; and we hope
that other researchers in this field will not be offended by
this approach. In the following are seven short stories that
briefly review recent research on disordered proteins pub-
lished by our group. These include the following: (1) A
bioinformatics study of the relationship between disorder
and function in the Swiss Protein Database [55-57]; (2)
An introduction of the molecular recognition feature
(MoRF) concept and characterization of various MoRFs
and MoRF-binding proteins [58-61]; (3) The mechanisms
by which one disordered region can bind to many part-
ners and by which many different disordered sequences
can bind to one site on one protein partner [62,63]
thereby contributing to the complex protein-protein inter-
action networks that are observed in nature; (4) The
observation that regions of mRNA that undergo alterna-
tive splicing code for disordered protein much more often
than they code for structured protein [64]; (5) A bioinfor-
matics study on conservation of intrinsic disorder in pro-
tein domains and protein families [65,66]; (6) An
introduction of the disordered proteins in disease (or D2)
concept, which is based on bioinformatics analysis that
indicate an abundance of intrinsic disorder in disease-
related proteins [38,67-74]. (7) A novel method for drug
discovery based on regions of disordered protein [75]. The
novel drug discovery method suggests how the observa-
tions in the first six studies might be put to practical use.
Intrinsic disorder and protein function
Our overall goal is to understand relationships between
amino acid sequence and protein function so that, given a
new sequence, possible functions could be suggested to
interested experimentalists for laboratory testing. For pro-
teins that form 3D structure, this is a well developed prob-
lem, but for intrinsically disordered proteins, work on this
problem is just beginning. First we will very briefly review
function prediction for structured proteins, and then we
will compare and contrast the very limited amount of
work in this area for intrinsically disordered proteins.
Function prediction for structured proteins
For structured proteins, sequence homology, if obvious
enough, can provide leads regarding protein function [76-
78]. Attempts to improve sequence matching for function
prediction have been carried out [79]. If no suggestive
homologue can be found, an alternative approach is to
determine the 3D structure and then to search structure
for functional clues, such as residues positioned in space
like the same or functionally similar residues in known
active sites [80-82]. Often evolution within a family of
related proteins can be helpful by means of the evolution-
ary trace approach [83]. Recent advances have been made
in the assessment of binding sites using both structural
and sequence homology [84]. For example, in order to
create an automated annotation process involving the
appropriate knowledge representation and prediction of
functionally important residue environments, a method
for extraction of features from sequence, sequence align-
ments, three-dimensional structure, and structural envi-
ronment conservation in catalytic sites was recently
proposed [85]. This tool was used to develop a model for
automated identification of catalytic residues in unanno-
tated protein structures. Application of this tool revealed
that catalytic residues can be reliably predicted even for
enzymes with new folds [85].
Function prediction for disordered proteins
Our first efforts to associate disorder with function were
carried out by manual literature searches. In the develop-
ment of our protein disorder predictors, we wanted to use
disorder characterized by methods other than missing
coordinates in X-ray structures, especially to test whether
disorder identified by different methods was different at
the amino acid sequence level [86]. Therefore, we had
accumulated manuscripts describing disordered proteins
and regions of disorder characterized by a variety of meth-
ods such as NMR, circular dichroism, small angle X-ray
scattering, and so on. In addition, we found many exam-
ples in which the disorder indicated by missing coordi-
nates in X-ray crystal structures had been confirmed by
other methods. Given these proteins and their associated
manuscripts, we then carried out literature searches for
functions associated with these well studied disordered
protein examples. Out of more than 100 disordered pro-
teins and regions, these manual searches identified 27 dif-
ferent functions, and at least one (and commonly more
than one) of these functions was found to be associated
with > 80% of the disordered proteins or regions. Of
course when a given disordered region or protein has no
associated function, it is unclear whether the given disor-
dered protein has no function or whether the function ofBMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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the given disordered protein has simply not yet been
found [87,88].
Among the various functions found for disordered
regions, even superficial analysis of "natively unfolded"
proteins revealed that many of them undergo disorder-to-
order transitions when stabilized by binding with specific
targets [37]. In fact, for the majority of proteins described
in that study, the existence of ligand-induced folding has
been established. Examples include induced structure for-
mation upon binding with DNA (or RNA) for protamines,
Max protein, high mobility group proteins HMG-14 and
HMG-17; osteonectine, SDRD protein, chromatogranins
A and B, Δ131Δ fragment of SNase, and histone H1. Other
examples include folding of cytochrome c in the presence
of heme, folding of ostecalcine induced by cations, sec-
ondary structure formation in parathyroid hormone
related protein induced by membrane association, struc-
ture formation in glucocorticoid receptor brought about
by association with trimethylamine N-oxide, folding of
histidine-rich protein II induced by heme; and structure
formation and compaction of prothymosin-α mediated
by zinc [37]. Therefore, among the major functions of
these unstructured, intrinsically disordered proteins are
nucleic acid binding, metal ion binding, heme binding
and interaction with membrane bilayers [37].
For structured proteins, proteins can be grouped together
if they display a common 3D fold as for example in the
CATH [89] and SCOP [90] databases. Often these proteins
with common folds have recognizable sequence similarity
and so can be grouped into evolutionarily-related protein
families. Sometimes, proteins have similar folds without
recognizable sequence similarity [91].
Sequence matching can be used to group disordered pro-
teins into related sets just as is done for structured pro-
teins. Perhaps because of the absence of structural
constraints, however, disordered proteins typically show
higher rates of mutations than do structured proteins [88],
so it is often more difficult to identify sequence relation-
ships among disordered proteins. The functionally impor-
tant residues within a disordered region tend to be a small
percentage of the total number of residues and so their
conservation tends to be obscured because of the muta-
tions of surrounding residues. Given these limitations
with regard to sequence matching for disordered proteins,
we have tried to develop alternative strategies.
Our attempts to develop clustering algorithms for finding
functionally related groups of disordered proteins have
yet not been very successful. These failures encouraged us
to develop an alternative approach based on predictions
of disorder. For this approach, we randomly partitioned a
set of disordered proteins into two subsets and developed
separate predictors for each group. We then applied the
two predictors to all the proteins, and repartitioned the
proteins based on which predictor gave the more accurate
results. We next retrained the two predictors using the two
redistributed sets, and then repeated the competition and
the redistribution. We carried out these steps iteratively
until the assigned partitions converged. To test for repro-
ducibility, we repeated the original random partition and
then repeated the entire experiment several times. The two
sets of proteins that resulted were mostly the same for the
different initializations, suggesting that the overall
approach gives a reproducible partition of the disordered
proteins into two groups [92].
Next, we repeated the overall process, but with three sub-
sets, four subsets, five subsets and six subsets instead of
two as tried originally. If this approach gives meaningful
results, improved agreement between disorder prediction
and observation would be expected due to increased
homogeneity within each subset. Prediction did improve
for the two and three subset partitioning, but not for four,
five nor six subset partitioning. We called the three subsets
of disordered proteins "flavors." The three subset flavors
were labeled V, C and S [92].
The functions associated with the various proteins in each
subset were then determined by literature searches. While
the different functions did not separate completely among
the different subsets, some of these flavors showed a
greater tendency to display particular functions, e.g. S was
associated with protein binding, V was associated with
RNA binding, and C was associated with posttranslational
modification sites [92].
More work on this approach might lead to improved
understanding of the relationships between sequence and
function for disordered proteins. To make the original
study more manageable, several simplifications were car-
ried out, and these simplifications likely diminished the
ability to discriminate different flavors of disorder.
Removing these simplifications might enable prediction
of function from sequence for at least some regions of dis-
order. Indeed, using an approach more standard than
ours, an important and remarkable success has recently
been achieved in the prediction of function from
sequence for disordered proteins [93].
More recently we carried out an analysis of the functional
annotation over the entire Swiss Protein database from a
structured-versus-disordered point of view [55-57]. The
first step was to find keywords associated with 20 or more
proteins in SwissProt. For each keyword-associated set,
one thousand length-matching and number-matching
sets of random proteins were drawn from Swiss Prot.
Order-disorder predictions were carried out for the key-BMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
Page 7 of 26
(page number not for citation purposes)
word-associated sets and for the matching random sets. If
a function described by a given keyword were carried out
by a long region of disordered protein, one would expect
the keyword-associated set to have a greater amount of
predicted disorder compared to the matching random
sets. The keyword-associated set would be expected to
have less prediction of disorder compared to the random
sets if the keyword-associated function were carried out by
structured protein. Given the predictions for the function-
associated and matching random sets, it is possible to cal-
culate the p-values, where a p-value > 0.95 suggests a dis-
order-associated function, a p-value < 0.05 suggests an
order-associated function, and intermediate p-values are
ambiguous.
Out of 710 keywords each being assigned to at least 20
proteins, 310 had p-values < 0.05, suggesting order-asso-
ciated functions, 238 had p-values > 0.95, suggesting dis-
order-associated functions, and the remainder, 170, gave
intermediate p-values, yielding ambiguity in the likely
function-structure associations [55-57].
When the functional keywords were partitioned into
eleven functional categories (Biological processes, cellular
components, developmental stage, etc.) order-associated
keywords were found for seven of the categories, but dis-
order-associated keywords were found for all eleven cate-
gories [55]. This observation supports a previous
conjecture that the functional repertoire is larger for disor-
dered proteins compared to that for structured proteins
[28]. Figure 2 represents summary of this analysis show-
ing relative distributions of these eleven functional cate-
gories among intrinsically disordered and ordered
proteins.
Considering the biological processes category, the order-
associated keywords nearly all described processes carried
out by (necessarily structured) enzymes (examples: amino
acid biosynthesis, purine biosynthesis, lipid synthesis,
etc) or by (necessarily structured) integral membrane pro-
teins (electron transport, sugar transport, ion transport).
On the other hand, in this same category, the disorder-
associated keywords described processes that typically
involve control or regulation (differentiation, transcrip-
tion, cell cycle, growth regulation, etc.). These observa-
tions slightly broaden an earlier conjecture that structured
proteins are primarily associated with catalysis while dis-
ordered proteins are associated with signaling and regula-
tion [28,94].
Finally, it is interesting to compare the individual key-
words associated with disorder prediction and with those
associated with the absence of disorder prediction (which
indicate structure-associated functions). Ribonucleopro-
tein and ribosomal protein are two disorder-associated
keywords with the highest Z-scores (values of 22.1 and
20.6, respectively). Interestingly, the Z-scores drop off to
values less than 10 after just a few proteins. Oxidoreduct-
ase and transferase are the order-associated keywords with
the highest Z-scores (values of -29.5 and -24.5, respec-
tively). Furthermore, the drop-off to values less than 10
occurs more slowly for the order-associated keywords.
One possible explanation is that the structured regions for
most of the proteins comprise most of the amino acid
sequence for the given protein whereas the disordered
region might comprise a small part of the entire sequence.
Another interesting feature of these data is that the top 20
order-associated keywords all end in "ase," indicating that
all are enzymes of one type or another. This suggests that,
for the order-associated keywords, the overall approach
works rather well. Although some laboratory genetic engi-
neering experiments have yielded molten globules with
enzymatic activity [95], to our knowledge currently
known natural enzymes are structured proteins.
Further studies on the disorder-associated key words
involved ranking the proteins in each category by Z-score
and then carrying out manual literature searches for evi-
dence of association between disorder and function for
the highest-ranking proteins. Indeed, for a significant frac-
tion of the high Z-score proteins with functions predicted
to be associated with disorder, an association between dis-
order and function was confirmed by these manual litera-
ture searches [56,57].
The tedious work of confirming the associations between
disorder and function needs to be carried out for more of
the protein groups in this study. It would then be interest-
ing to study these groups of proteins by the methods
Functional anthology of intrinsic disorder Figure 2
Functional anthology of intrinsic disorder.
Order-related
Disorder-related
Swiss-Prot Functional 
Keywords
Col 2: 9 
Col 2: 4 
Col 2: 17 
Col 2: 34 
Col 2: 72 
Col 2: 143 
Col 2: 37 
Col 2: 12 
Col 2: 4 
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described above or by new methods to find sequence-
function relationships for disorder-associated functions.
Such work would provide the basis for enabling research-
ers to infer (disorder-associated as well as order-associ-
ated) function from sequence.
Intrinsically disordered proteins as interactors: 
MoRFs, linear motifs, "preformed elements" and 
"fuzzy complexes"
Protein-protein and protein-nucleic acid interactions,
being central to many processes in molecular biology,
often involve coupled folding and binding of at least one
of the partners and sometimes involve coupled binding
and folding for both partners. When a protein-protein
interaction involves an intrinsically disordered partner,
the methods developed for predicting protein-protein
interactions based on known structures are simply not
applicable. For intrinsically disordered proteins, new
methods and new approaches are needed. The importance
of predicting regions of disordered proteins that bind to
partners of course depends on the commonness of such
proteins.
Finding MoRFs
We noticed several particular examples in which binding
sites within disordered regions coincided with dips in our
disorder prediction plots, especially PONDR VL-XT plots
[96], so we developed a predictor of binding sites within
disordered regions based on disorder prediction [58]. We
suggested that these segments contain molecular recogni-
tion features or MoRFs. This feature consists of a short
region (on the order of 20 residues) that undergoes a dis-
order-to-order transition that is stabilized by binding to
its partner; this short region is within a segment of disor-
der. These MoRFs were proposed to function in the recog-
nition of protein or nucleic acid partners [58]. Figure 3
shows that a region of hirudin involved in interaction
with thrombin has a peculiar and well-recognizable pat-
tern, where short region of predicted order is surrounded
by extended regions predicted disorder [73]. This specific
pattern was used to develop a unique bioinformatics tool
dedicated to the identification of potential protein-pro-
tein sites in intrinsically disordered proteins, namely the
α-MoRF identifier [58]. The application of this identifier
to various protein datasets revealed that the frequency of
α-MoRFs in various types of proteins is highest in those
associated with signaling and lowest in the metabolic
enzymes. Evidently, these elements have advantages for
cell signalling, e.g., allowing among others the decoupling
of specificity/affinity, which provides a mechanism by
which the strength and duration of signaling events can
evolve separately [58].
This first α-MoRF identifier was developed using a train-
ing data set of a limited size (a set of 13 proteins contain-
ing 15 potential α-MoRFs). All the training examples were
correctly identified by the algorithm, suggesting the possi-
bility of overfitting. Recently, the prediction algorithms
was improved by (1) including additional α-MoRF exam-
ples and their cross species homologues in the positive
training set, (2) carefully extracting monomer structure
chains from the Protein Data Bank (PDB) as the negative
training set, (3) including attributes from recently devel-
oped disorder predictors, secondary structure predictions,
and amino acid indices, and (4) constructing neural net-
work based predictors and performing validation [61].
The sensitivity, specificity, and accuracy of the resulting
predictor, α-MoRF-PredII, were 0.87 ± 0.10, 0.87 ± 0.11,
and 0.87 ± 0.08 over 10 cross-validations, respectively
[61].
Linear motifs
A completely different approach for finding protein-pro-
tein interaction sites is to search for the few, function-
associated residues that remain conserved in the sea of
changes among the surrounding disordered regions. Such
conserved residues have been called Eukaryotic Linear
Motifs (ELMs) and methods for their discovery from
sequence, analogous to finding transcription factor bind-
ing sites, have been developed [97-99]. The overall idea is
to search for overabundance of particular residues in
regions of sequence that lie outside of Pfam domains. The
sets of sequences to be tested typically bind to one specific
partner. Thus, evidently the conserved residues represent
a binding motif within a linker between (Pfam) structured
domains or in a disordered tail at the carboxy or amino
terminus of a (Pfam) structured domain [99].
Currently, when the search is carried out for ELMs, Pfam
domains are excluded. This exclusion typically results in
increased focus on regions of intrinsic disorder. However,
some Pfam domains contain regions predicted to be dis-
ordered with a high degree of conservation [65]. Further-
more, these disordered regions are often implicated in
biological functions [66], thus giving a set of disorder-
associated functional regions that are not considered by
the current ELM analysis. Extending the current ELM anal-
ysis to include these Pfam-associated regions of disorder
should be done.
ELMs are identified by their over-representation among
protein sequences that bind to a common partner [97-99].
Short linear motifs (SLiMs) are also identified as specific
sequence patterns that are over-represented in proteins
that bind to a common partner, but the algorithms used
to discover SLiMs employ filters to remove homologous
proteins whereas the ELM-discovery algorithms do not
[100]. Thus, ELMs and SLiMs are both identified as
sequence patterns in multiple proteins that bind to a com-
mon target, with the SLiM-containing set likely to beBMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
Page 9 of 26
(page number not for citation purposes)
entirely nonhomologous but with no such restriction on
the ELM-containing set.
MoRFs differ from ELMs and SLiMs in not depending on
a specific sequence motif, but rather upon a pattern in a
disorder prediction output. Yet, interestingly, recent anal-
ysis suggests that linear motifs (LMs) (thus not differenti-
ating between ELMs and SLiMs) show high overlap with
MoRFs [101]. Taken all together, these observations sug-
gest that regions of intrinsic disorder often play a role in
protein-protein interactions. In addition, there are numer-
ous documented cases where the binding of these disor-
PONDR-based analysis of hirudin and thrombin Figure 3
PONDR-based analysis of hirudin and thrombin. The correspondence of PONDR® VL-XT predictions and regions of 
known structure are shown. Two PDB structures are presented5HIR (left) and 1NO9 (right) – where each chain is color 
coded – folded N-terminal domain of hirudin (yellow, disulphide bridges are shown by maroon lines), acidic C-terminal domain 
of hirudin (red) bound to a heavy chain of thrombin (blue), and light chain of thrombin (green). These color codes are also used 
for bars in two PONDR® VL-XT plots – (top) hirudin and (bottom) thrombin – to indicate the positions of the regions of 
known structure in the context of the PONDR® VL-XT predictions. Drawn over these bars, hash marks show the residues in 
contact with other chains, where the color of the hash mark corresponds to the color code of the chain in contact. Black hash 
mark in the PONDR® VL-XT plot for thrombin corresponds to the factor Xa cleavage site. A predicted α-MoRF region of 
hirudin is shown in corresponding PONDR® VL-XT plot as a pink bar.
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dered regions is coupled to their folding (reviewed in
[102]).
Discriminative features of MoRFs and their binding 
partners
Experimentalists have successfully used our MoRF predic-
tors to discover sites of protein-protein interactions that
were subsequently confirmed in laboratory experiments
[103,104], and other studies independently verified the
predicted interactions [105]. Application of this algorithm
to databases of genomics and functionally annotated pro-
teins indicates that α-MoRFs are likely to play important
roles protein-protein interactions involved in signaling
events. In agreement with this model, recent computa-
tional studies of such binding showed that the disordered
partner might contain a "conformational preference" for
the structure it will take upon binding, and that these so-
called "preformed elements" tend to be helices [58-
60,106]. An important output of induced folding is that
this coupled binding and folding determines a unique
combination of high specificity and low affinity [107] typ-
ical of the signaling and regulation interactions. More
recent studies show that at least some disordered regions
display template-dependent folding rather than pre-
formed elements (see below, [62,63]).
A search of PDB has revealed more than 2,500 short
regions of one protein (MoRFs) associated with a globular
domain of a second protein. Many of these short regions
are related to each other, so the number reduces to several
hundred families when they are grouped by sequence sim-
ilarity. Most of these interactions are associated with sign-
aling or regulation [59]. This PDB analysis revealed that
MoRFs can be divided into three subtypes according to
their structures in the bound state: α-MoRFs form α-heli-
ces, β-MoRFs form β-strands, and ι-MoRFs form structures
without a regular pattern of backbone hydrogen bonds
[59,60]. We have also found numerous complex MoRFs,
which represent mixtures of these three structural forms.
Illustrative examples of structurally divergent MoRFs are
shown in Figure 4.
Although only a few MoRFs have been studied experimen-
tally, our bioinformatics analysis suggests that all MoRFs
are intrinsically disordered in the absence of their binding
partners. This was done using the criteria of Gunasekaran
et al. [108], who showed that the complexes of intrinsi-
cally disordered proteins have much larger interface and
surface areas than those of complexes formed by pairs of
structured proteins. In other words, Gunasekaran et al.
have demonstrated that intrinsic disorder in the unbound
state is reflected in the structures of the bound state
through relatively large surface and interface areas.
Using the approach and control datasets described above
[108], a structural analysis of the bound structures of
MoRFs in our dataset of 62 α-, 20 β- and 176 ι-MoRF was
carried out (Figure 5). Almost all MoRFs in the dataset
gave positions above the order-disorder boundary sug-
gested previously, which indicates that these regions are
likely to be disordered in isolation, while all ordered pro-
teins gave positions below this boundary, which indicates
these proteins are likely to be ordered in isolation [59].
Next, we examined several geometric and physiochemical
criteria of MoRF-partner complexes [60]. The comparison
of the compositions and physiochemical properties of
MoRF and MoRF partner interface residues with the inter-
face residues of homodimers, heterodimers, and antigen-
antibody complexes indicated that there are significant
differences in residue composition and several geometric
and physicochemical properties that can be used to dis-
criminate, with a high degree of accuracy, between various
interfaces in protein interaction datasets [60].
The MoRF-partner complex formation was shown to be
accompanied not only by the binding-induced folding of
MoRFs, but also by noticeable structural changes in the
MoRF partners which vary widely, from small scale move-
ments to large scale movements and from partial folding
Examples of structurally divergent MoRFs Figure 4
Examples of structurally divergent MoRFs. MoRFs (red 
ribbons) and partners (green surface) are shown (A) An α-
MoRF, Proteinase Inhibitor IA3, bound to Proteinase A (PDB 
entry 1DP5). (B) A β-MoRF, viral protein pVIc, bound to 
Human Adenovirus 2 Proteinase (PDB entry 1AVP). (C) An 
ι-MoRF, Amphiphysin, bound to α-adaptin C (PDB entry 
1KY7). (D) A complex-MoRF, β-amyloid precursor protein 
(βAPP), bound to the PTB domain of the neuron specific 
protein X11 (PDB entry 1X11). Partner interfaces (gray sur-
face) are also indicated.
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to partial unfolding [60]. Figure 6 represents several illus-
trative examples of structural changes induced in MoRF
partners by the complex formation. We did not find a sin-
gle complex that was not accompanied by some structural
adjustments in a MoRF partner induced by complex for-
mation [60].
"Fuzzy complexes"
Recently, it was suggested that intrinsically disordered
proteins are able to become ordered following binding to
their partner(s) and that this 'restores' the primacy of the
classical structure-function paradigm according to which
protein function is equated with a well-defined 3D struc-
ture [109]. However, the careful analysis of structures of
many protein complexes in PDB revealed that this state-
ment is not generally true. In fact, even in the crystal struc-
tures, the part(s) of the complexes that contribute
productively to binding and function are structurally ill-
defined, and cannot be described by a single conforma-
tional state, in other words demonstrating a significant
amount of structural disorder or polymorphism in pro-
tein complexes [109]. According to the authors of this
study, such disorder can be grouped into four mechanistic
categories, where the crucial protein component might
adopt a few or multiple alternative conformations ('poly-
morphic' model), or it might remain disordered but con-
nect ('clamp' model) or neighbour ('flanking' model)
ordered binding region(s). At the extreme, the majority or
the whole of the bound IDP might remain disordered
('random' model). These observations paved the ground
for the "fuzziness" phenomenon according to which func-
tional disorder in protein-protein complexes is wide-
spread covering a continuous spectrum of structural states
from static to dynamic disorder and from segmental to
full disorder [109]. It has been also argued that fuzziness
in protein-protein interactions is beneficial in a variety of
functional settings. Its existence, however, has thus far
been largely overlooked because of the bias in our experi-
Bioinformatics evidence for the unstructured character of MoRFs in their unbound states Figure 5
Bioinformatics evidence for the unstructured character of MoRFs in their unbound states. Surface and interface 
area normalized by the number of residues in each chain for MoRF and the OC datasets.
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mental approaches to obtain well-defined structures of
complexes, and also with respect to our understanding of
the functional relevance of such states [109].
Disordered signalling conduits
A four-step disordered signalling conduit has been
recently proposed to explain the functionality of the cyc-
lin-dependent kinase inhibitor p27Kip1 (p27) [9]. p27 is a
small intrinsically unstructured protein [110] regulating
cell proliferation through interactions with cyclin-
dependent kinases (Cdks) [111]. A critical step in the G1
to S phase transition of cell division is the phosphoryla-
tion-dependent removal of the inhibitory p27 molecule
from the surface of the cyclin A/Cdk2 complex. The initial
level of p27 in the G1 phase is high, and this high level
blocks the progression from G1 to S phase via the inhibi-
tion of Cdk2/cyclin A and Cdk2/cyclin E [112,113].
Therefore, the level of p27 has to decrease significantly for
the Cdk2/cyclin complexes to become fully activated and
for cell division to progress. The p27 level is controlled via
translational regulation and ubiquitination-dependent
proteolysis [114,115]. Ubiquitination of p27 at the G1/S
transition is regulated by its phosphorylation [116]. In
addition, abnormal ubiquitination-mediated degradation
of p27 is common in human tumors [117].
Recently, a thorough study combined both biophysical
and computational tools to reveal a complex four-step
conduit model explaining the phosphorylation-mediated
dislocation of p27 from cyclinA/Cdk2 [9]. In this model,
the starting point is a ternary complex formed between
p27 and the cyclin A/Cdk2 heterodimer. In the first step,
Structural changes in MoRF partners Figure 6
Structural changes in MoRF partners. Ribbon representation MoRF partners shown unbound (blue ribbons) and bound 
(green ribbons) to MoRFs (red ribbons). (A) Small scale structural alterations in CheY induced by binding of the MoRF region 
of FliM (PDB entries: unbound – 1U8T and bound – 1F4V). (B) Large scale structural alterations in calmodulin induced by bind-
ing to the MoRF of GAD (PDB entries: unbound – 1CLL and bound – 1NWD). (C) Partial disorder-to-order transition in 
PCNA induced by binding to the MoRF of FEN-1 (PDB entries: unbound – 1RWZ and bound – 1RXZ). (D) Partial order-to-
disorder transition in Bcl-xL induced by binding to the MoRF of Bim (PDB entries: unbound – 1PQ0 and bound – 1PQ1).
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Y88 of p27Kip1 becomes phosphorylated by a non-receptor
tyrosine kinase (NRTK), thereby making the Cdk2 active
site accessible and leading to the Cdk2-controlled phos-
phorylation of p27 at T187. This latter phosphorylation
promotes ubiquitination of p27 by the SCFSkp2 E3 lyase
complex. Finally, ubiquitinated p27 is degraded by the
26S proteasome, activating the cyclin A/Cdk2 complex
and promoting the G1 to S phase transition [9].
The flexibility and lack of structure are key features for this
p27 signaling conduit. The p27 chain encircles the cyclin
A/Cdk2 complex and interacts with surface features at sev-
eral well separated locations [118]. The lack of buried sur-
face area within a single p27 chain in the complex further
supports a fully disordered state for unbound p27. Such
lack of internal structure facilitates the unzippering of
complexes, which allows part of a complex to separate
while maintaining other interactions [3]. In the case of
p27, the flexibility allows part of the protein to separate
from the surface of the ternary complex while many of the
contacts remain intact. The flexibility of the tethered but
otherwise free disordered segment further enables p27 to
fold back, thereby accelerating phosphorylation via a uni-
molecular mechanism. The lack of structure also likely
facilitates entry of p27 into the proteasome cavity where
digestion occurs.
One of the possible explanations for the very complex and
highly coordinated four-step signal conduit is that the
biology for this particular example requires the disruption
of an already-formed complex rather than the inhibition
of complex formation [119]. Because of flexibility, the dis-
ruption of the p27/cyclin A/Cdk2 complex can proceed in
a stepwise, segmental fashion, which likely provides a
kinetic advantage for the overall process. By this
approach, the interactions are dispersed bit-by-bit rather
than all at once [119].
Furthermore, intrinsic disorder in the p27 conduit pro-
vides several general features that are useful for signalling
interactions such as binding diversity, large interaction
surface and uncoupled specificity and affinity. In fact,
because a significant part of the binding energy has to be
spent to fold a flexible protein, lack of structure and flexi-
bility in the unbound state provide interactions with a
mechanism to have both high specificity and low affinity,
with the low affinity providing the basis for easy reversi-
bility. On the other hand, a large interaction surface cou-
pled with a high flexibility allows segmental association
and dissociation, thereby providing additional opportu-
nities for regulation and control as demonstrated in the
conduit model [119].
Intrinsic disorder and protein-protein 
interaction networks
Networks linking protein-protein interactions typically
involve a few proteins binding to many partners (called
hub protein or hubs) and many proteins interacting with
just a few partners. How these networks acquired their
architecture and how they evolved are both very active
areas of research [120-122]. A News and Views article
[123], which was longer than the article [124] it discussed,
raised the possibility that the ability of hub proteins to
bind to many partners might depend on new principles.
In essence, the News and Views article raised the question:
what feature of protein structure enables binding diver-
sity?
Pauling's 70-year old conjecture that unfolded, dynamic
protein ensembles could contribute to binding diversity
provided the beginning for the present article. Since Paul-
ing's initial work, several additional researchers have sug-
gested that lack of structure (e.g. disorder) could
contribute to the ability of a protein to bind to multiple
partners, with several of these researchers providing exper-
imental data in support of this concept [3,69,125,126].
To test the roles of disorder in the specific case of protein-
protein interaction networks, we first collected a set of
structurally characterized hub proteins [127]. Several hub
proteins were found to be entirely disordered, from one
end to the other, and yet to be capable of binding large
numbers of partners. Other hubs contained both ordered
and disordered regions. For these hubs, many, but not all,
of the interactions mapped to the regions of disorder. Two
highly structured hubs were found. For both of these
structured hubs, 14-3-3 and calmodulin, the binding
regions of their partner proteins were found to be intrin-
sically disordered [128,129]. However, it has proven very
difficult to globally test whether structured hubs bind to
disordered partners. A difficulty with such studies is that
the partners often contain both order and disorder, and
the disordered regions typically comprise only small frac-
tions of the partner sequences. Thus, without knowing the
binding region of each partner, it is difficult to estimate
whether or not disorder is involved in any particular inter-
action.
Overall, our initial study suggested two primary mecha-
nisms by which disorder is utilized in protein-protein
interaction networks, namely one disordered region bind-
ing to many partners and many disordered region binding
to one partner. Several groups have tested these overall
ideas further via bioinformatics studies on collections of
hub proteins, and these studies support the common use
of disordered regions by hub proteins to bind to multiple
partners [130-134]. These bioinformatics studies include
further refinement of the analysis with the suggestion thatBMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
Page 14 of 26
(page number not for citation purposes)
disorder is very commonly used for regions that bind
sequentially to multiple partners (so called "date hubs"
[134]).
Without specific regard to protein-protein interaction net-
works, several years ago we considered possible roles of
disorder in protein interactions. In that study, we pro-
posed that "one-to-many" signaling be used to describe
the capacity of one disordered region to bind to many
partners. We further suggested that "many-to-one" signal-
ing be used to describe how flexibility could enable mul-
tiple disordered regions to bind to one site on one partner
[3]. While numerous papers suggest that flexibility could
enable one protein to bind to many partners, we might
have been the first to suggest that flexibility would provide
a means for multiple sequences to bind to a common
partner.
Recently we studied the detailed structures for a one-to-
many example (namely, p53 using its disordered regions
to bind to many partners), and we also studied the struc-
tures of a many-to-one example (namely, 14-3-3 using its
single binding site to associate with many different disor-
dered partners having different amino acid sequences).
Using a collection of structures currently available in the
PDB, a single disordered region of p53 is observed to form
a helix, a sheet, and two different irregular structures when
binding to four different partners, respectively. The set of
residues involved in these one-to-many interactions have
an identical core set with slightly different extents on
either side [62].
The accessible surface area (ASA) with regard to the sol-
vent molecules can be calculated from the three dimen-
sional structure of a protein analytically [135] or
numerically [136]. The amount of ASA becoming inacces-
sible upon complex formation is likewise easily estimated
[137] and can be presented as the ΔASA.
Plotting the ΔASA versus the sequence position gives a
binding profile (Figure 7). Interestingly, the single region
of p53 bound to four different partners gives completely
different binding profiles. For this example, the different
partners "read" the same sequence in entirely different
ways [62].
For a partner-binding disordered region, the binding pro-
file is highly localized. In contrast, for a partner-binding
structured protein, the binding profile comprises two (or
more) localized regions that are considerably separated
along the sequence. The separation results from bringing
together different regions to form the active site in the
structured protein. The DNA binding domain of p53 also
has a complex, distinctive binding profile that is different
from the profiles when binding to p53BP1 and p53BP2
[62]. The p53BP1 and p53BP2 profiles have similar p53
sequence localizations, but the detailed shapes of the pro-
files are quite distinctive.
Using structures currently in the PDB), five disordered
sequences associated within a single binding groove in
14-3-3 provide an example of many-to-one signaling
interactions. As suggested previously [3] the flexibility
plays a major role enabling different sequences to fit into
one binding site. Both backbone and side-chain flexibili-
ties are needed to accomplish the structural shifts needed
for the different sequences to fit into the common binding
site [62].
Our earlier publication failed to consider the flexibility on
the structured side of the complex (e.g. the flexibility in
14-3-3) for many-to-one signaling interactions. In this
example, the structured protein side of the complex also
uses flexibility to accommodate the binding of the many
disordered segments to a common binding site.
The now famous induced-fit hypothesis was first pro-
posed in 1958 [138]. In Koshland's original publication,
a thought-experiment involving different amino acid side
chains binding to a common site was described. For the
different sequences to bind, an "induced fit" was sug-
gested to be required in order to accommodate the differ-
ent structures of the different side chains. The current text-
book examples of induced fit describe an entirely different
type of binding in which fairly rigid domains shift upon
binding to their ligand. However, 14-3-3 binding to mul-
tiple peptides of different sequences is evidently the first
example that closely corresponds to Koshland's original
induced fit hypothesis. Comparing the interactions of 14-
3-3 with the different peptide sequences confirms
Koshland's original induced fit hypothesis, and these
comparisons provide insight regarding the degree of struc-
tural change upon binding (manuscript in preparation).
Intrinsic disorder and alternative splicing
Two or more mature mRNAs are produced from a single
precursor pre-mRNA by the inclusion and omission of dif-
ferent segments in a process called "alternative splicing"
[139,140]. The "exons" are joined to form the mRNA and
the "introns" are left out [141]. So far alternative splicing
has been commonly observed only in multicellular
eukaryotes [142]. For humans and other mammals, 40 –
60% the genes yield proteins via the alternative splicing
mechanism [143-145], and multiple proteins are often
produced from a single gene. Alternative splicing very
likely provides an important mechanism for enhancing
protein diversity in multicellular eukaryotes [146].BMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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Alternative splicing has affects on a diversity of protein
functions such as protein-protein interactions, ligand
binding, and enzymatic activity [147-149]. Therefore it
comes as no surprise that abnormal alternative splicing
has been associated with numerous human diseases,
examples being myotonic dystrophy [150], Axoospermia
[151], Alzheimer's [152] and cancer [153].
Alternative splicing that maps to protein structure would
often lead to dysfunctional protein folding, most often
Sequence and structure comparison for the four overlapping complexes in the C-terminus of p53 Figure 7
Sequence and structure comparison for the four overlapping complexes in the C-terminus of p53. (A) Primary, 
secondary, and quaternary structure of p53 complexes. (B) The ΔASA for rigid association between the components of com-
plexes for each residue in the relevant sequence region of p53. The two hatched bars indicate acetylated lysine residues. Histo-
gram of conserved predicted disorder effective length classes by kingdom.
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causing loss of function. In some cases, however, the alter-
natively spliced structured protein can maintain function,
albeit typically with a reduction in activity.
For alternative splicing that maps to structure, the altera-
tions are generally of small size, are usually located on the
protein surface, and are most often located in coil regions
[154]. These features support efforts to predict the affects
of alternative splicing on protein structure (and function)
by homology modeling [155] and by a more sophisti-
cated structural modeling and analysis [154]. Given the
small sizes and locations of the changes resulting from
alternative splicing, the different splice variants were pre-
dicted to fold into the same overall structures, with only
slight structural perturbations that could be functionally
important.
The structural implications given above are interesting,
but only a small fraction of alternative splicing events
have been mapped to structured proteins. Given that 40%
to 60% of mammalian (human) genes are estimated to
undergo alternative splicing, and given that there are sev-
eral thousand mammalian proteins in PDB [156], we
would expect to find several thousand examples to study.
So far, however, despite exhaustive searches of PDB, only
20 examples have been reported [154]. Given the failure
to find a significant number of examples of alternative
splicing that map to regions of structure, what is the alter-
native?
To further understand the relationship between alterna-
tive splicing and structure we searched for alternatively
spliced isozyme pairs and were able to find just five such
pairs with structures determined for both partners [157-
161]. Consistent with the modeling paper results dis-
cussed above [154], the folding of the protein isoforms
pairs was nearly identical. The lack of significant structural
perturbations occurred because alternatively spliced seg-
ments were either short regions on the surface of the struc-
ture (for two pairs) or were disordered regions (for the
remaining three pairs). With regard to the two spliced
structured segments, the larger structural perturbation cor-
responded to the omission of a short helix in the shorter
splice variant. This omission led to a slight rearrangement
of the neighboring secondary structure elements adjusted
to accommodate the lack of the very short intervening
helix. As for the three pairs for which the alternative splic-
ing mapped to disordered regions, this suggests a possible
explanation for the missing examples of splicing that map
to the structures in the PDB.
Given the above data, we hypothesized that the protein
folding problems discussed above would be solved for
different isoforms if the alternatively spliced regions of
mRNA were to code for regions of intrinsically disordered
protein. If alternative splicing were to map to disordered
regions, both multiple and long splice variants would be
allowed because structural perturbation would not be a
problem.
To test whether alternative splicing is associated with dis-
order, we built a collection of human proteins with struc-
turally characterized regions of both structure and
disorder. Next, we searched for data on alternative splic-
ing for all of these proteins. At that time we were able to
find just 46 human proteins with 75 alternatively spliced
segments all of which were located in structurally charac-
terized regions [64].
Figure 8 shows that of these 75 alternatively spliced
regions of RNA, 43 (57%) coded for entirely disordered
protein, 18 (24%) coded for both ordered and disordered
protein (with the splice boundaries very often in, or very
near to, the disordered regions), and just 14 (19%) coded
for fully structured regions [64].
While small in number, these 43 disorder-associated alter-
natively spliced regions and 18 mixed-structure regions
are significantly larger than the 14 regions associated with
regions of structure. Nevertheless, it would be very useful
to enlarge the dataset.
To increase the number of examples, we identified all of
the proteins in SwissProt labeled as having alternatively
spliced isoforms, giving 558 proteins with 1,266 regions
that are absent from one isoform due to alternative splic-
Abundance of intrinsic disorder in alternatively spliced  regions Figure 8
Abundance of intrinsic disorder in alternatively 
spliced regions. Fractions of alternatively spliced regions of 
RNA coded for entirely disordered protein, for both 
ordered and disordered protein, and for fully structured 
regions are shown as red, violet and blue pieces of the pie 
chart respectively.
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ing. Next, we predicted disorder/order for these alterna-
tively spliced proteins and regions. As a control, we also
predicted disorder/order for the 46 structurally character-
ized proteins and for their 75 regions that are affected by
alternative splicing. For both datasets, we plotted the fre-
quency of observation versus per cent disorder, with the
disorder binned at the 20% level. The 75 alternatively
spliced regions of known structure gave almost perfect
agreement between predictions and observations. For the
1,266 regions from SwissProt, the predicted disorder
closely matched the corresponding predictions for the 75
with known structure. These data strongly suggest that
alternative splicing occurs mostly in regions of RNA that
code for disordered protein.
Our previous predictions estimated that about 50% of
mammalian proteins have disordered regions of 30 resi-
dues or longer [94]. These prediction results are similar to
the estimate of 40% to 60% of mammalian genes that
undergo alternative splicing. Thus, the overall likely fre-
quency of intrinsic disorder is certainly high enough for
80% of alternative splicing events to occur in such regions.
In several sections given above, the various roles of disor-
der in protein functions and in protein-protein interac-
tion networks are discussed. Modification of such
functions including protein-protein interaction networks
could be readily accomplished by alternative splicing
within disordered regions. Thus, a linkage between alter-
native splicing and signaling by disordered regions pro-
vides a novel and plausible mechanism for understanding
the origins of cell differentiation, which ultimately gave
rise to multicellular organisms in nature [64]. New studies
are needed to test these ideas.
Conservation of intrinsic disorder in protein 
domains and families
Many proteins possess complex domain structure. In fact,
~65% proteins in unicellular organisms and > 80% pro-
teins in metazoa, are multidomain proteins [162]. Tradi-
tionally, a domain is considered to be an independent (or
semi-independent) part of a protein molecule that could
fold autonomously, i.e., separately from the rest of the
protein chain. Structural domains vary in length from
between about 25 amino acids up to 500 amino acids in
length. For structured proteins, domains have been
described as units of independent folding [163], of com-
pact structure [164] or of function and evolution [165].
Obviously, these definitions, being valid individually,
may overlap and a conserved, compact structural domain
is likely to be able to fold autonomously. Combinatorial
usage of various structural and functional units creates a
vast number of multidomain and multifunctional pro-
teins [166], in which each domain may fulfill its own
function independently, or in a concerted manner with its
neighbors.
Recently [65,66], to identify the prevalence, characteris-
tics, and functions of conserved disordered regions within
protein domains and families, a database was created that
stores the amino acid sequences of nearly one million
proteins and their domain matches from the InterPro
database [167]. InterPro is a computational resource inte-
grating several protein family and domain databases,
including PRINTS, PROSITE, Pfam, ProDom, SMART and
TIGRFAMs [167]. These million proteins were analyzed
using PONDR® VL-XT disorder predictor and regions of
sequence corresponding to domains were aligned using a
multiple sequence alignment tool. Combining disorder
prediction and conservation data, many regions of con-
served predicted disorder were found within protein
domains. This analysis identified 3653 regions of con-
served disorder prediction, found within 2898 distinct
InterPro entries [65]. Importantly, regions of conserved
disorder prediction were found in protein domains from
all available InterPro member databases. Furthermore,
they were found in all kingdoms of life, including viruses
[65]. Figure 9 emphasizes this fact and shows also that the
majority of regions of conserved predicted disorder were
short, with less than 10% of these regions founnd to
exceed 30 residues in length. Most of the long conserved
disordered regions were in domains from eukaryotic or
viral proteins [65]. This is in line with our previous work,
which found that long regions of intrinsic disorder were
much more prevalent in eukaryotes than in prokaryotes
[30,48,168]. This work has also shown that in addition to
well-known conserved structural domains, protein
domains and families have regions of conserved disorder.
Most conserved disordered regions had sequence conser-
vation greater than or equal to that in conserved ordered
regions within the same protein. This indicated that disor-
der tendencies were kept in these proteins, suggesting that
important functions likely depend on the disordered
regions [65].
These regions of predicted disorder were found to be con-
served within a large number of protein families and
domains. Although many think of such conserved
domains as being structured, in fact a significant number
of them contain regions of disorder that are likely to be
crucial to their functions [65]. The next crucial question
was: What are the purposes of the regions of conserved
predicted disorder? To answer this question, a functional
repertoire of these regions was analyzed and a variety of
functions were found to be associated with domains con-
taining conserved disorder [66]. The most common were
DNA/RNA binding and protein binding. Many ribosomal
proteins also were found to contain conserved disordered
regions. Other functions identified included membraneBMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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translocation and amino acid storage for germination.
Due to limitations of both current knowledge and the
methodology implemented in that study, it was not deter-
mined whether these functions were directly associated
with the predicted disordered region [66]. Because in
most cases the region of conserved predicted disorder cov-
ered only a part of the domain, it is possible that the dis-
ordered region is not required for the known function of
the domain. However, given that this disorder is con-
served through nearly all members of the domain, it
seems likely that the disorder plays a role in at least one
important function of the domain, whether that function
is known or unknown. Furthermore, the functions associ-
ated with conserved disorder were in agreement with the
functions found in other studies to correlate to disordered
regions. We have established that intrinsic disorder may
be more common in bacterial and archaeal proteins than
previously thought, but this disorder is likely to be used
for different purposes than in eukaryotic proteins, as well
as occurring in shorter stretches of protein [66].
The D2 concept: abundance of untrinsic disorder 
in disease-related proteins
Proteins are crucial for life, so it is not surprising that their
dysfunction can cause pathological conditions. Indeed, a
significant number of diseases arise from the failure of a
specific peptide or protein to adopt its proper structure.
Such diseases are associated with protein misfolding.
Observed consequences of misfolding include protein
aggregation (and/or fibril formation), loss of normal
function, and gain of toxic function. Some proteins
exhibit a marked tendency to assume a pathologic confor-
mation, and this tendency becomes increasingly evident
with aging or at persistently high concentrations caused
by some condition. Sometimes endogenous factors,
including for example chaperones, intracellular or extra-
cellular matrixes, other proteins and small molecules, can
alter the conformation of a pathogenic protein and
thereby increase its propensity to misfold. Other causes of
misfolding and misfunction include point mutation(s),
exposure to internal or external toxins, impaired post-
translational modifications (phosphorylation, advanced
glycation, deamidation, racemization, acetylation, etc.),
an increased probability of degradation, impaired traffick-
ing, loss of binding partners or oxidative damage. These
various factors can act independently or in complex asso-
ciations. Intrinsically disordered proteins known as
"hubs" associate with large numbers of partners (see
above). Furthermore, such proteins often exhibit signifi-
cant structural variability, forming different monomeric,
oligomeric and insoluble conformations depending on
the environment and suggesting that some of these pro-
teins fold in a template-dependent manner (e.g., see
[68]). From these observations, we proposed that the
development of conformational diseases may originate,
not only from misfolding, but also from misidentifica-
tion, misregulation and missignaling [73]. That is, muta-
tions and/or changes in the environment could cause
Abundance of conserved predicted disordered regions in various organisms Figure 9
Abundance of conserved predicted disordered regions in various organisms. Histogram of conserved predicted dis-
order effective length classes by kingdom.
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protein confusion, thereby reducing the ability to recog-
nize appropriate binding partners and leading instead to
the occurrence of deadly aggregates.
Data scattered in literature for individual proteins unam-
biguously show that some proteins involved in human
diseases such as cancer, Parkinson's disease and other
synucleinopathies, Alzheimer's, prion diseases, diabetes,
and cardiovascular disease are either completely disor-
dered or contain long disordered regions. This immedi-
ately raises the question of how abundant are such
proteins in various pathological conditions. To answer
this question, several sets of proteins related to various
diseases, including cancer and cardiovascular disease
(CVD), were collected and analyzed using a number of
disorder predictors [67,70,71]. Results of these analyses
are systemized in Figure 10, which shows percentages of
proteins with ≥ 30 consecutive residues predicted to be
disordered in datasets of proteins associated with cancer,
CVD, neurodegenerative disease and diabetes [73]. This
illustrates that intrinsic disorder is highly prevalent in
CVD-, diabetes-, cancer, and neurodegenerative disease-
related proteins, being comparable with that of signaling
proteins and significantly exceeds the level of intrinsic dis-
order in eukaryotic proteins from SWISS-PROT and in
non-homologous, structured proteins from the PDB. In
fact, 79% of cancer-associated and 61% of CVD-associ-
ated proteins were found to contain predicted regions of
disorder of 30 residues or longer [67,70,71,73].
Using CVD as an illustrative example, the hypothesis that
high level of intrinsic disorder could be important for
function of disease-related proteins, and for the control
and regulation of processes associated with cardiovascular
disease was confirmed by finding that 198 α-MoRFs were
predicted in 101 proteins from the CVD dataset [71]. The
mentioned number of MoRFs is important because these
features provide the starting point for disorder-based drug
discovery (see below). A comparison of disorder predic-
tions with the experimental structural and functional data
for a subset of the CVD-associated proteins indicated
good agreement between predictions and observations.
Additional confirmation of the high prevalence of intrin-
sically disordered proteins in human diseases came from
the described above functional annotation over the entire
Swiss Protein database from a structured-versus-disor-
dered point of view [55-57]. In fact, this analysis revealed
that many diseases are strongly correlated with proteins
predicted to be disordered. Contrary to this, we did not
find disease-associated proteins to be strongly correlated
with absence of disorder [57]. Among disease-related
Swiss-Prot keywords strongly associated with intrinsic dis-
order were oncoproteins, malaria, trypanosomiasis,
human immunodeficiency virus (HIV) and acquired
immunodeficiency syndrome (AIDS), deafness, obesity,
cardiovascular disease, diabetes mellitus, albinism, and
prion [57]. Thus, intrinsic disorder is very common in dis-
ease-associated proteins, giving rise to the disorder in dis-
orders concept, which we are calling the "D2 concept."
[73].
This high abundance of intrinsic disorder in proteins
involved in various diseases suggests that they possess a
number of specific features that make them key players in
the development of pathological conditions. Intrinsically
disordered regions or entire proteins are among major cel-
lular regulators, recognizers and signal transducers. Their
functionality is modulated via a number of posttransla-
tional modifications and also can be tuned and made
organ/tissue specific via the alternative splicing of corre-
sponding mRNAs. Many intrinsically disordered regions
and intrinsically disordered proteins can fold (completely
or partially) upon interaction with corresponding binding
partners, ensuring low-affinity/high-specificity binding.
They possess multiple binding specificity and they are
able to participate in one-to-many and many-to-one inter-
actions [73]. All this makes intrinsically disordered
regions and intrinsically disordered proteins very attrac-
tive targets for the development of a novel class of drugs
aiming modulation of protein-protein interactions.
Abundance of intrinsic disorder in disease-associated pro- teins Figure 10
Abundance of intrinsic disorder in disease-associated 
proteins. Percentages of disease associated proteins with ≥ 
30 to ≥ 100 consecutive residues predicted to be disordered. 
The error bars represent 95% confidence intervals and were 
calculated using 1,000 bootstrap re-sampling. Corresponding 
data for signaling and ordered proteins are shown for the 
comparison. Analyzed sets of disease-related proteins 
included 1786, 487, 689, and 285 proteins for cancer, CVD, 
neurodegenerative disease and diabetes, respectively.
Length of disordered regions, aa
P
r
o
t
e
i
n
s
,
 
%
0
20
40
60
80
PDB_S25 
Signaling 
Cancer 
CVD 
Neurodegenerative 
Diabetes 
 >=30    >=40    >=50    >=60    >=70    >=80   >=90    >=100BMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
Page 20 of 26
(page number not for citation purposes)
Intrinsic disorder and drug discovery
For a long time protein-protein interactions have been a
potential source of drug targets. Indeed, determining the
protein interactome by systems biology approaches and
understanding of these results at a deeper level points to
interesting drug targets [169]. Despite such interest, devel-
oping drug molecules that block protein-protein interac-
tions has not yet been successful [170,171]. Indeed, our
searches of the current literature have failed to yield even
one currently used drug molecule that functions by inhib-
iting a protein-protein interactions.
Even though there has been little success in finding drugs
that act by blocking protein-protein interactions, several
promising molecules are encouraging a renewed interest
in this approach [172-175]. As pointed out in these recent
discussions, several interesting drug-like lead compounds
apparently function by blocking protein-protein interac-
tions, and these leads are being actively pursued via drug-
discovery strategies.
One very important interaction of interest, specifically the
p53/Mdm2 interaction, has been the focus of multiple
drug-discovery studies [176-178]. We became interested
in this example because the binding region of p53 is
intrinsically disordered [179]. However, the papers that
discuss this interaction as a promising drug target don't
even mention the disorder-to-order transition for the p53
partner.
Bioinformatics and computational structural biology
tools were employed to investigate this interaction, and
these studies revealed several features that explained why
this region is so promising as a drug target. Next, we
searched for similar features in other proteins contained
in the human proteome. By this approach we found thou-
sands of possible new drug targets involving one disor-
dered partner. Many examples of these new targets are
found for each of the major diseases [75]. Clearly a great
deal of work is needed to find actual drug molecules based
on these bioinformatics studies, but in our view these new
leads merit systematic study.
A protein-protein interaction involving one disordered
partner and one structured partner has several features
that are consistent with being a good target for drug dis-
covery. First, unlike most interfaces between two struc-
tured proteins, the interface between one structured and
one disordered partner is almost never flat. Usually the
structured partner has a cleft in the interface, while the dis-
ordered region typically becomes organized into a helix or
other structure with hydrophobic side chains that project
away from the backbone and into the cleft. Such features
occur over and over in our MoRF dataset [59] and also in
the examples used to develop the MoRF predictors
[58,61]. With respect to the p53/Mdm2 interaction, the
p53 binding site is predicted to be an α-MoRF, and this
binding site contains hydrophobic side chains that project
deeply into the cleft located on the surface of the Mdm2
partner.
For these disorder-based interactions, the disordered part-
ner "morphs" from disorder-to-order, and, therefore,
some of the binding energy must be spent to overcome
the higher entropy of the unfolded state. Such an interac-
tion is therefore likely to be weaker than a similar-sized
interaction between two structured proteins. This entropy
penalty means that such interactions will likely be easier
to block with a small molecule competitor as compared to
a similar interaction between two structured proteins.
Protein disorder is not discussed or even mentioned in
any of the papers touting protein-protein interactions as
new targets for drug discovery. Nevertheless, 4 of the 8
examples described in these recent reviews [172,174]
depend on one structured partner and one disordered
partner. Furthermore, in 3 of the 4 examples, the disor-
dered segments, or at least part of the disordered segment
morphs into a helix upon binding (see Figure 11). Thus,
the p53/Mdm2 complex is not alone in being a disorder-
based interaction that is blocked by a small drug-like mol-
ecule. Many more examples are likely to appear in the
coming years, and we anticipate that some of these exam-
ples will eventually lead to new drug molecules.
Conclusion
The concepts regarding drug discovery can be linked with
the concepts regarding alternative splicing. Together,
these two concepts suggest approaches that could lead to
the development of tissue-specific drugs via taking into
account tissue-specific alternative splicing in disordered
regions that form protein-protein interactions that can be
blocked by small molecules. Such tissue-specific drug
molecules might have fewer side effects than current drug
molecules.
The concepts regarding drug discovery can be linked with
the concepts regarding protein-protein interactions.
Together these two concepts suggest two distinct possibil-
ities. First is the possibility of one drug molecule blocking
one protein-protein interaction (for one-to-many signal-
ing interactions). Second is the possibility of one drug
molecule blocking many interactions (for many-to-one
signaling interactions). Experiments could be designed to
focus specifically on these distinct classes of interactions
to determine possible differential biological effects of
these two distinct possibilities.
The concepts of drug discovery can be linked with the con-
cepts regarding the functions of intrinsically disorderedBMC Genomics 2008, 9(Suppl 2):S1 http://www.biomedcentral.com/1471-2164/9/S2/S1
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regions. Together these concepts suggest new strategies for
finding drugs aimed at a wide variety of signaling and reg-
ulatory functions.
We began to apply bioinformatics to the set of disordered
proteins about 12 years ago, with our first paper being
published slightly more than 10 years ago [86]. During
this decade our understanding of the biological functions
IDPs as drug targets Figure 11
IDPs as drug targets. Protein-protein interactions involving α-helical or β-strand portion of the partners are used to design 
small molecules for cancer drugs. A. A ribbon diagram of complex of β-catenin (light colors) and T cell factor (red) was regen-
erated from PDB 1G3J. The structure of β-catenin is consisted of 12 tri-helical repeats (except the repeat 7, which just has two 
helical units). Small molecules from a natural-product library were screened and a couple of inhibitors were found. However, 
the binding sites for the small molecule inhibitors were not clear. B. A ribbon diagram of complex of MDM2 (green) and P53 
fragment (red) was regenerated from PDB 1YCR. Small molecule inhibitors were designed based on the structure of the helical 
fragment of P53. C. A ribbon diagram of complex of Bcl-xL (green) and BAK fragment (red) was regenerated from PDB 1BXL. 
Small molecules were designed based on the 20-residue helix of BAK to inhibit the interaction. D. A ribbon diagram of com-
plex of XIAP (green) and Smac fragment (red) was regenerated from PDB 1G3F. Small molecule inhibitors were designed 
based on the β-strand fragment (AVPIAQKSE) of Smac.
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and importance of these proteins has undergone a signif-
icant improvement. Perhaps the next decade will pave the
way for practical outcomes (such as new drug molecules)
from the study of these proteins.
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